NCT03556033View on ClinicalTrials.gov

Effect of Dapagliflozin on IAH in T1DM

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 23, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Diabetes Mellitus, Type 1HypoglycemiaHypoglycemia Unawareness
Interventions
DRUG

Dapagliflozin

8 weeks treatment with dapagliflozin on top of insulin treatment

DRUG

Placebo oral capsule

8 weeks treatment with placebo capsules on top of insulin treatment

Trial Locations (1)

6500HB

Radboud university medical center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT03556033 - Effect of Dapagliflozin on IAH in T1DM | Biotech Hunter | Biotech Hunter